|
Market Closed -
Japan Exchange
14:30:00 07/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 2,303.00 JPY | -2.23% |
|
-2.85% | +10.03% |
| 09-01 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 09-01 | White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies | MT |
| Market Cap | 4,129B 26.77B 23.02B 21.65B 19.76B 36.96B 2,531B 37.08B 257B 99.23B 1,296B 101B 98.32B | P/E 2027 * |
11.2x | P/E 2028 * | 11.9x |
|---|---|---|---|---|---|
| Enterprise Value | 4,070B 26.38B 22.69B 21.34B 19.48B 36.43B 2,495B 36.55B 253B 97.81B 1,278B 99.08B 96.91B | EV / Sales 2027 * |
1.75x | EV / Sales 2028 * | 1.69x |
| Free-Float |
98.88% | Yield 2027 * |
3.49% | Yield 2028 * | 3.6% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4503 | Delayed | |
OTC Markets
| ALPMF | Delayed | |
|
Tradegate
| YPH | Real-time | |
|
Boerse Muenchen
| YPH | Real-time | |
|
Deutsche Boerse AG
| YPH | Delayed | |
|
Börse Stuttgart
| YPH | Delayed |
Last Transcript : Astellas Pharma Inc.
| 1 day | -2.23% | ||
| 1 week | -2.85% | ||
| Current month | -2.89% | ||
| 1 month | +0.63% | ||
| 3 months | +6.57% | ||
| 6 months | -4.20% | ||
| Current year | +10.03% |
| 1 week | 2,297.5 |  | 2,430.5 |
| 1 month | 2,250 | | 2,455 |
| Current year | 2,041 | | 2,717 |
| 1 year | 1,557.5 | | 2,717 |
| 3 years | 1,243.5 | | 2,717 |
| 5 years | 1,243.5 | | 2,717 |
| 10 years | 1,243.5 | | 2,717 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 64 | 10/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 01/11/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 10/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 64 | 01/06/2019 |
| Director/Board Member | 59 | 01/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.23% | -2.85% | +35.39% | +3.60% | 27.06B | |
| -0.88% | -2.15% | +58.05% | +105.26% | 1,024B | |
| -1.15% | +2.68% | +54.25% | +74.19% | 663B | |
| -1.44% | +0.38% | +20.65% | +76.13% | 453B | |
| -0.95% | +0.23% | +30.91% | +37.78% | 352B | |
| -3.18% | +1.78% | +22.62% | +41.55% | 304B | |
| +0.30% | +0.67% | +0.60% | +11.25% | 252B | |
| -1.55% | +1.11% | +54.15% | +75.59% | 236B | |
| +0.02% | +2.24% | -13.83% | -55.80% | 206B | |
| -0.15% | +3.65% | +31.24% | +103.39% | 187B | |
| Average | -1.10% | +1.07% | +29.40% | +47.29% | 370.54B | |
| Weighted average by Cap. | -1.05% | +0.61% | +37.65% | +66.44% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,329B 15.1B 12.98B 12.21B 11.15B 20.85B 1,428B 20.92B 145B 55.97B 731B 56.7B 55.46B | 2,155B 13.97B 12.02B 11.3B 10.32B 19.29B 1,321B 19.36B 134B 51.8B 677B 52.47B 51.32B |
| Net income | 356B 2.31B 1.98B 1.87B 1.7B 3.19B 218B 3.2B 22.12B 8.55B 112B 8.66B 8.47B | 333B 2.16B 1.85B 1.74B 1.59B 2.98B 204B 2.99B 20.67B 7.99B 104B 8.1B 7.92B |
| Net Debt | -59.18B -384M -330M -310M -283M -530M -36.28B -531M -3.68B -1.42B -18.58B -1.44B -1.41B | -481B -3.12B -2.68B -2.52B -2.3B -4.3B -295B -4.32B -29.88B -11.55B -151B -11.7B -11.44B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/09/26 | JP¥2,303.00 | -2.23% | 3,348,800 |
| 04/09/26 | JP¥2,355.50 | -2.54% | 5,484,800 |
| 03/09/26 | JP¥2,417.00 | +1.15% | 4,891,400 |
| 02/09/26 | JP¥2,389.50 | -1.04% | 6,357,100 |
| 01/09/26 | JP¥2,414.50 | +1.81% | 5,726,800 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
Select your edition
All financial news and data tailored to specific country editions
